or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    GMAB F Genmab A/S 1.00
    APLM F Apollomics Inc. -1.14
    GNLX F Genelux Corporation 12.28
    PPBT F Purple Biotech Ltd. -1.95
    CRIS F Curis, Inc. 0.00
    BCAB F BioAtla, Inc. 8.33
    PBYI F Puma Biotechnology Inc -2.58
    PYXS F Pyxis Oncology, Inc. -2.04
    LYEL F Lyell Immunopharma, Inc. 0.00
    OPK F OPKO Health Inc. 0.41
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Small Cell Lung Cancer Solid Tumors Medicine Melanoma Cancer Immunotherapy Drugs Lung Cancer Multiple Myeloma NSCLC Acute Myeloid Leukemia Antineoplastic Drugs Breast Cancer Cancer Treatment Carcinoma Hematological Malignancies Immunotherapy Non Small Cell Lung Carcinoma

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.57
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.49
    FDM C First Trust DJ Select MicroCap ETF 1.33
    FORH D Formidable ETF 0.68
    XBI C SPDR S&P Biotech ETF 0.38
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare BBC to FORH Compare CNCR to FORH Compare CNCR to XBI

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        Jul 3 APLM Apollomics announces changes in executive leadership team
        Jul 3 APLM Apollomics Announces Updated Strategic Focus and Leadership Team Changes
        Jul 3 BCAB Insider Traders Lose US$67k As BioAtla Drops
        Jul 2 PPBT Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gross Proceeds
        Jul 2 OPK NextPlat Expands E-Commerce Program in China to Include Broad Retail Distribution and Adds Digital/Social Media Marketing Capabilities with New Marketing Partner
        Jul 1 PPBT Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
        Jul 1 GMAB AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jun 28 PYXS Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
        Jun 28 OPK Investors in OPKO Health (NASDAQ:OPK) have unfortunately lost 70% over the last three years
        Jun 28 GMAB AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 GMAB Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma
        Jun 27 GMAB Completion of Share Buy-back Program
        Jun 27 GMAB FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
        Jun 27 BCAB BioAtla to Host Virtual R&D Day on Clinical Program and Pipeline Updates on July 25, 2024
        Jun 27 PPBT Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Cancer Study with CM24 Regarding a Potential Predictive Biomarker for Overall Survival Benefit
        Jun 27 GMAB Genmab, AbbVie win FDA nod for relapsed follicular lymphoma therapy
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Biopharmaceutical Clinical Medicine Small Cell Lung Cancer Solid Tumors Medicine Melanoma Cancer Immunotherapy Drugs Lung Cancer Multiple Myeloma NSCLC Acute Myeloid Leukemia Antineoplastic Drugs Breast Cancer Cancer Treatment Carcinoma Hematological Malignancies Immunotherapy Non Small Cell Lung Carcinoma
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags